The store will not work correctly when cookies are disabled.
(+/-)-6-(benzo[b]thiophen-2-yl)-5,6-dihydroimidazo[2,1-b]thiazole hydrochloride
ID: ALA3092295
PubChem CID: 72737028
Max Phase: Preclinical
Molecular Formula: C13H11ClN2S2
Molecular Weight: 258.37
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: C1=CN2CC(c3cc4ccccc4s3)N=C2S1.Cl
Standard InChI: InChI=1S/C13H10N2S2.ClH/c1-2-4-11-9(3-1)7-12(17-11)10-8-15-5-6-16-13(15)14-10;/h1-7,10H,8H2;1H
Standard InChI Key: VAMVMXMVUABESY-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 20 0 0 0 0 0 0 0 0999 V2000
14.6363 -3.5473 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
13.1838 -4.9868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4109 -4.7302 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.1848 -5.8186 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.9207 -5.3963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3968 -6.0692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9717 -4.7363 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
11.0950 -5.3989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9695 -6.0712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4598 -5.4051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6080 -4.7330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6122 -6.0689 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
9.8261 -5.8164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8247 -4.9933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1125 -4.5849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4011 -4.9983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4065 -5.8244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1194 -6.2291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3 2 2 0
4 2 1 0
5 3 1 0
6 4 1 0
7 2 1 0
5 8 1 0
9 4 1 0
10 7 1 0
10 9 2 0
6 5 1 0
8 11 2 0
11 14 1 0
13 12 1 0
12 8 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 258.37 | Molecular Weight (Monoisotopic): 258.0285 | AlogP: 3.83 | #Rotatable Bonds: 1 |
Polar Surface Area: 15.60 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.10 | CX LogP: 3.31 | CX LogD: 3.31 |
Aromatic Rings: 2 | Heavy Atoms: 17 | QED Weighted: 0.77 | Np Likeness Score: -0.97 |
References
1. Debray J, Chang L, Marquès S, Pellet-Rostaing S, Le Duy D, Mebarek S, Buchet R, Magne D, Popowycz F, Lemaire M.. (2013) Inhibitors of tissue-nonspecific alkaline phosphatase: design, synthesis, kinetics, biomineralization and cellular tests., 21 (24): [PMID:24183741] [10.1016/j.bmc.2013.09.053] |